Erlotinib Completed Phase 2 Trials for Adult Glioblastoma / Adult Giant Cell Glioblastoma / Adult Gliosarcoma / Recurrent Adult Brain Tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00445588Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
NCT00039494Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors